Comments

Neurocrine Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NBIXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$115.71

-1.81-1.54%

At close: -

$115.71

0.000.00%

After Hours: May 9, 4:00 PM EDT

Q1 2025 Earnings were released on Mon May 5th, after the market close

The most recent conference call was at 16:30 PM, 5 days ago Click to view past webcast

Neurocrine Biosciences (NBIX) Forecast

News Earnings Neurocrine Biosciences (NBIX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Neurocrine Biosciences Stock Price, Quotes and Forecasts | NASDAQ:NBIX | Benzinga

Explore Neurocrine Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NBIX.

Open	$118.04
Close	$115.71
Volume / Avg.	1.32M / 1.70M
Day Range	$115.66 - $119.67
52 Wk Range	84.23 - 157.98
Market Cap	$11.45B
P/E Ratio	39.84
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	6.05%
Days to Cover	2.82

Recent News

Neurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target

Neurocrine stock gains as Q1 EPS beats estimates; Ingrezza sales climb 8% YoY with record new patients and strong analyst price target hikes.

Vandana Singh

FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

In The Holiday Shortened Easter Week, These Large-Cap Stock Were Top Performers (Apr 14-Apr 18): Are These In Your Portfolio?

Top performers last week: ServiceTitan, Summit Therapeutics, YPF, Eli Lilly, MicroStrategy, America Movil, Ericsson, Insmed, Diamondback, Neurocrine Biosciences.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$118.04
Close	$115.71
Volume / Avg.	1.32M / 1.70M
Day Range	$115.66 - $119.67
52 Wk Range	84.23 - 157.98
Market Cap	$11.45B
P/E Ratio	39.84
Dividend Yield	-
Exchange	NASDAQ
RSI	61
Short Interest	6.05%
Days to Cover	2.82

About Neurocrine Biosciences, Inc.

Sector

Health Care

Industry

Biotechnology

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for...

Got Questions? Ask

Analyze NBIX's market performance

What is NBIX's current market cap?

What is NBIX's P/S ratio?

What is the consensus rating for NBIX?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Neurocrine Biosciences (NBIX) stock?

You can purchase shares of Neurocrine Biosciences (NASDAQ:NBIX) through any online brokerage.

View our list of the best stock brokerages

Who are Neurocrine Biosciences (NBIX) competitors?

Other companies in Neurocrine Biosciences’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Roivant Sciences (NASDAQ:ROIV), Amgen (NASDAQ:AMGN) and United Therapeutics (NASDAQ:UTHR).

What is the forecast, or price target, for Neurocrine Biosciences (NBIX) stock?

Neurocrine Biosciences has a consensus price target of $160.28.

What is the current price for Neurocrine Biosciences (NBIX)?

The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $115.71 last updated May 9, 2025 at 4:00 PM EDT.

Does Neurocrine Biosciences (NBIX) pay a dividend?

There are no upcoming dividends for Neurocrine Biosciences.

When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?

Neurocrine Biosciences’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Neurocrine Biosciences (NBIX) going to split?

There is no upcoming split for Neurocrine Biosciences.

What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.